Logo

microfluidics

Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab

The two companies have exclusively licensed PNNL's microfluidic NanoPOTS platform and entered into a research agreement with EMSL to develop it toward commercial use.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies

The companies are conducting a study to evaluate their combined platforms for the detection and characterization of CTCs in prostate cancer.

Deepcell, UCLA Partner to Study AI Cell Biology Platform

The company said the collaboration is the first under an academic partnership program to refine and advance its technology and explore specific applications.

TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research
Premium

ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers.

May 17, 2021

Namocell, SingLab Technologies Ink Distribution Agreement for Singapore

May 12, 2021

Nuclera Acquires E Ink Digital Microfluidics Business

May 12, 2021

Berkeley Lights to Launch Subscription Option for Smaller Biotech Firms
Premium

May 11, 2021

Berkeley Lights Q1 Revenues Grow 35 Percent

Mar 31, 2021

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

Mar 29, 2021

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

Mar 18, 2021

Namocell, OLS OMNI Life Science Sign European Distribution Agreement

Mar 3, 2021

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy
Premium

Feb 25, 2021

Miroculus Raises $45M in Extended Series B Financing

Feb 10, 2021

Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth

Jan 25, 2021

Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets
Premium

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

Dec 18, 2020

BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership

Dec 7, 2020

Deepcell Closes $20M Series A Financing Round

Nov 18, 2020

Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx
Premium

Nov 17, 2020

New NGS-Based Tissue Analysis Method Offers Spatial Detail on Transcriptome, Proteins
Premium

Nov 9, 2020

Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform
Premium

Nov 5, 2020

Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing

Oct 8, 2020

Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost

Sep 29, 2020

Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.